Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -29.50x is 71% above its 4-year average of -102.87x, near the high end of its 4-year range (-561.49x–-13.72x).
As of the fiscal period ended Sunday, December 31, 2023. 78.65% above its 12-month average of -138.16x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2023 (2023-12-31): -29.50x.
INTEREST COVERAGE RATIO
-29.50x
INTEREST COVERAGE RATIO AVG TTM
-138.16x
INTEREST COVERAGE RATIO AVG 3Y
-138.16x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+78.65%
CURRENT VS 3Y AVG
+78.65%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-362.72%
vs the sector median at left
NewAmsterdam Pharma Company N.V.
Market Cap
$2.60B
Interest Coverage Ratio
-29.50x
TTM Avg
-138.16x
3Y Avg
-138.16x
5Y Avg
N/A
Market Cap
$2.61B
Interest Coverage Ratio
-0.37x
TTM Avg
0.59x
3Y Avg
204.00x
5Y Avg
353.37x
Market Cap
$2.60B
Interest Coverage Ratio
-8.77x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.56B
Interest Coverage Ratio
N/A
TTM Avg
7.78x
3Y Avg
5.30x
5Y Avg
5.30x
Market Cap
$2.66B
Interest Coverage Ratio
1.89x
TTM Avg
1.89x
3Y Avg
0.94x
5Y Avg
0.94x
Market Cap
$2.70B
Interest Coverage Ratio
2.79x
TTM Avg
3.64x
3Y Avg
5.04x
5Y Avg
5.11x
Market Cap
$2.71B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.49B
Interest Coverage Ratio
N/A
TTM Avg
5.09x
3Y Avg
6.01x
5Y Avg
15.92x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewAmsterdam Pharma Company N.V. (NAMS) | $2.60B | -29.50x | -138.16x | -138.16x | N/A |
| Neogen Corporation (NEOG)vs › | $2.61B | -0.37x | 0.59x | 204.00x | 353.37x |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | -8.77x | N/A | N/A | N/A |
| Privia Health Group, Inc. (PRVA)vs › | $2.56B | N/A | 7.78x | 5.30x | 5.30x |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | 1.89x | 1.89x | 0.94x | 0.94x |
| Precigen, Inc. (PGEN)vs › | $2.69B | -27.57x | N/A | N/A | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | 2.79x | 3.64x | 5.04x | 5.11x |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | N/A | N/A | N/A | N/A |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.49B | N/A | 5.09x | 6.01x | 15.92x |
| AtriCure, Inc. (ATRC)vs › | $2.73B | -0.59x | 11.23x | 11.23x | 11.23x |
Interest Coverage
-29.5x
Debt/Equity
0.00
Current Ratio
9.03
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-12-31 | -29.50x |
| 2023-09-30 | -51.47x |
| 2023-06-30 | -13.72x |
| 2023-03-31 | -34.61x |
| 2022-12-31 | -561.49x |
| 2020-09-30 | -44.07x |
| 2020-06-30 | -44.07x |
| 2020-03-31 | -44.07x |
